Phenazone/ Procaine/ Potassium Hydroxyquinoline Sulphate
Indications
Registered South African indications:
- Otitis media
- Infection or inflammation of the ear
Cautions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Contraindications
- Hypersensitivity to the active ingredient or any of the excipients in this combination product
- Wherever possible, children with earache should be taken to a doctor
Cautions
Route of application
- For external use only
Response to therapy
- If the earache does not respond quickly to treatment, the patient should consult a doctor, as ear infections can be dangerous
Adult dosage
Forms avail. in SA and covered in this monograph: dro
Otitis media
Infection of the ear
Inflammation of the ear
Phenazone/ Procaine/ Potassium hydroxyquinoline sulphate
50/10/1 (mg/1g)
- Otic (dro): 2-3 drops into the affected ear(s), 4hrly
Paediatric dosage
Not established for use in children
Special populations
Recommendations for this combination product as per highest risk category when comparing individual active ingredients
Pregnancy
Breastfeeding
Renal Impairment
Hepatic Impairment
Elderly
Adverse reactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Phenazone
Skin and Subcutaneous Tissue Disorders
- Skin eruptions
Immune disorders
- Hypersensitivity reactions
Procaine
Central Nervous System Disorders
- Nervousness
- Dizziness
- Tremors
- Seizures
- Myasthenia gravis
Cardiovascular Disorders
- Hypertension
- Bradycardia
- Ventricular arrhythmias
- Cardiac arrest
Gastrointestinal Disorders
- Nausea and vomiting
Skin and Subcutaneous Tissue Disorders
- Urticaria
- Oedema
Sensory Disorders
- Blurred vision
Interactions
Combination products may have additional pharmacological effects not accounted for by the action of the individual ingredients
Phenazone
- No information available
Procaine
- Buproprion
- Donepezil
- Hyaluronidase
- St John's wort
- Sulphonamides
Monitoring
None routine
Mechanism of action
Phenazone
Thought to act primarily in the central nervous system, increasing the pain threshold by inhibiting cyclooxygenase, involved in prostaglandin synthesis.
Procaine
Procaine is an ester type local anaesthetic, which stabilises the neuronal membranes and prevents initiation and transmission of nerve impulses, by decreasing the transient increase in permeability to sodium through the inhibition of voltage-gated sodium channels.
Potassium hydroxyquinoline sulphate
This ingredient has no pharmacological effect.
Dosage forms
- Ear drops
Formulation
COMBINATION PREPARATIONS
Phenazone/ Procaine/ Potassium hydroxyquinoline sulphate
Ear drops (per g) 50mg/10mg/1mg
- Universal Earache (Litha) originator
References
1. https://drive.google.com/drive/folders/1Lp5GDBBxwGt5n1u4sfXByNT4lq_y40Ez (Mims_08/06/2017_Universal earache drops) 2. https://drive.google.com/drive/folders/1Lp5GDBBxwGt5n1u4sfXByNT4lq_y40Ez (07/02/1975_Litha_Universal earache drops_sol) **No SPC available
Brands & products
1 product · cached snapshot- Universal Earache
EAREar drops· 1 product
from R29.02| Product | Strength | Pack | Applicant | Min price |
|---|---|---|---|---|
| Universal Earache Drops solution | 50 mg/g;mg/g;mg/g | 15 | Acino Pharma (Pty) Ltd | R29.02 |
Medical aid coverage
data not yet integrated- Comprehensive Series—
- Executive Plan—
- KeyCare Series—
- Priority Series—
- Saver Series—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- BonClassic—
- BonComprehensive—
- BonEssential—
- BonFit Select—
- BonSave—
- BonStart—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Beryl—
- Emerald—
- Onyx—
- Ruby—
- Sapphire—
- Tanzanite One—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.
- Aquarium Option—
- Efficiency Option—
- Marine Option—
Formulary scraper pending — coverage tier, co-pay and authorisation requirements will appear here once data is ingested.